LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a Massachusetts‐based medical device company specializing in the development, manufacturing and marketing of specialty vascular surgical devices. Since its founding in 1981 by vascular surgeon Dr. George D. LeMaitre, the company has focused on addressing unmet clinical needs in the treatment of peripheral artery and venous diseases. Headquartered in Burlington, Massachusetts, LeMaitre Vascular has maintained its public listing since 2004 and continues to operate with a commitment to quality, innovation and physician collaboration.
The company’s product portfolio spans a broad range of vascular interventions, including valvulotomes for in situ vein bypass procedures, occlusion balloons for temporary arterial blockages, endoscopic vessel harvesting systems and plasma‐derived patch materials for blood vessel repair. LeMaitre Vascular also offers a suite of atherectomy devices, angioplasty balloons, specialty catheters and hemostatic agents designed to streamline surgical workflows and improve patient outcomes. Ongoing investments in research and development have expanded its offerings to include advanced sealing and anastomotic devices that meet evolving clinical requirements.
LeMaitre Vascular serves physicians and healthcare institutions in over 80 countries across North America, Europe, Latin America and the Asia-Pacific region. The company employs a hybrid commercial model with direct sales operations in key markets and established distribution partnerships in regions with emerging demand. Its global footprint enables close collaboration with vascular and cardiovascular surgeons, interventional radiologists and treatment centers that manage chronic peripheral artery disease and venous insufficiency.
Leadership remains rooted in the company’s founder‐driven ethos, with a management team committed to advancing minimally invasive vascular solutions. Under the guidance of President and Chief Executive Officer Mark Dunn and supported by a seasoned board of directors, LeMaitre Vascular emphasizes customer support, regulatory compliance and strategic acquisitions to drive sustainable growth. With more than four decades of industry experience, the company continues to leverage physician feedback and clinical evidence to refine its products and expand into new markets.
AI Generated. May Contain Errors.
